Cargando…
Many are called, few are chosen: the role of science in drug development decisions
Pharmaceutical firms are extremely selective in deciding which patented drug candidates are taken up into clinical development, given the high costs and risks involved. We argue that the scientific base of drug candidates, and who was responsible for that scientific research, are key antecedents of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008718/ https://www.ncbi.nlm.nih.gov/pubmed/37359814 http://dx.doi.org/10.1007/s10961-022-09982-6 |